2m 2m 2m 2m 2m 2m 2m
Pacira BioScienc (PCRX)
NASDAQ
$25.36$0.00 (0.00%)
Price as of Sep 11, 2026 7:30 PM EDT- $1.0BMarket Cap
- -6.49%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Pacira BioScienc (PCRX)
$25.36$0.00 (0.00%)
PCRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $25.36 | ||
Change | +$0.20 (+0.79%) | ||
Open | $25.43 | ||
High | $25.57 | ||
Low | $25.18 | ||
Previous Close | $25.16 | ||
Volume | 549,240 | ||
30-Day Average Volume | 531,070 | ||
1-Week Change | -3.76% | ||
1-Month Change | 4.02% | ||
1-Year Change | -6.49% | ||
3-Year Change | -24.05% | ||
5-Year Change | -54.22% | ||
Fundamentals | |||
Shares Outstanding | 39.9M | ||
Total Assets | $1.2B | ||
Market Cap | $1.0B | ||
Enterprise Value | $1.2B | ||
Period: QTR TTM FY | |||
Revenue | $190.5M | ||
Net Income | $4.7M | ||
Free Cash Flow | $56.1M | ||
EBIT | $6.2M | ||
EBITDA | $27.5M | ||
Net Working Capital | $493.2M | ||
EPS | $0.12 | ||
Enterprise Value/EBITDA | 45 | ||
Enterprise Value/Revenue | 7 | ||
P/B | 2 | ||
P/E | 211 | ||
PEG | 3 | ||
Price/Free Cash Flow | 18 | ||
Price/Operating Cash Flow | 18 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue